Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 3, 1997, Pages 405-409

  Shonekan, Dokun ^a   Handwerger, Sandra ^b   Mildvan, Donna ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 DEOXY 7 DIMETHYLAMINO 9 (N,N DIMETHYLGLYCINAMIDO) 6 NORTETRACYCLINE; ANTIBIOTIC AGENT; CL 331002; CLINAFLOXACIN; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; MINOCYCLINE; TEICOPLANIN; TROVAFLOXACIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; ENTEROCOCCUS FAECALIS; GRAM POSITIVE COCCI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; NAPHTHYRIDINES; QUINOLONES; TEICOPLANIN; TETRACYCLINES; VANCOMYCIN; VIRGINIAMYCIN;

EID: 0030951636     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.3.405     Document Type: Article

References (10)

1. Wise, R., Ashby, J. P. & Andrews, J. M. (1988). In vitro activity of PD 127,391, an enhanced-spectrum quinolone. Antimicrobial Agents and Chemotherapy 32, 1251-6.
2. Collins, L. A., Malanoski, G. J., Ellopoulos, G. M., Wennersten, C. B., Ferraro, M. J. & Moellering, R. C. (1993). In vitro activity of RP59500, an injectable streptogramin antibiotic against vancomycin-resistant Gram-positive organisms. Antimicrobial Agents and Chemotherapy 37, 598-601.
3. Eliopoulos, G. M., Klimm, K., Eliopoulos, C. T., Ferraro, M. J. & Moellering, R. C. (1993). In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of Gram-positive bacteria. Antimicrobial Agents and Chemotherapy 37, 366-70.
4. Testa, R. T., Petersen, P. J., Jacobus, N. V., Sum, P. E., Lee, V. J. & Tally, F. P. (1993). In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Antimicrobial Agents and Chemotherapy 37, 2270-7.
5. Pass, R. J. (1991). In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci. Antimicrobial Agents and Chemotherapy 35, 553-9.
6. Handwerger, S., Raucher, B., Altarac, D., Monka, J., Marchione, S., Singh, K. V. et al. (1993). Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clinical Infectious Diseases 16, 750-5.
7. Speer, B. S., Shoemaker, N. B. & Salyers, A. A. (1992). Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clinical Microbiology Reviews 5, 387-99.
8. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition; Approved Standard M7-A3. NCCLS, Villanova, PA.
9. National Committee for Clinical Laboratory Standards. (1992). Methods for Determining Bactericidal Activity of Antimicrobial Agents; Tentative Guideline M26-T. NCCLS, Villanova, PA.
10. Wise, R. & Andrews, J. M. (1994). In vitro activities of two glycylcyclines. Antimicrobial Agents and Chemotherapy 38, 1096-102.